The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant
Alexandra B Hogan, Sean L Wu, Patrick Doohan, View ORCID ProfileOliver J Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M Riley, David S Khoury, View ORCID ProfileNeil M Ferguson, Azra C Ghani
doi: https://doi.org/10.1101/2022.01.17.22269222
Alexandra B Hogan
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Sean L Wu
2Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
Patrick Doohan
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Oliver J Watson
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
3London School of Hygiene and Tropical Medicine, London, UK
Peter Winskill
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Giovanni Charles
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Gregory Barnsley
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Eleanor M Riley
4Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, UK
David S Khoury
5Kirby Institute, University of New South Wales, Sydney, Australia
Neil M Ferguson
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Azra C Ghani
1MRC Centre for Global Infectious Disease Analysis, Jameel Institute, School of Public Health, Imperial College London, London, UK
Article usage
Posted January 18, 2022.
The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant
Alexandra B Hogan, Sean L Wu, Patrick Doohan, Oliver J Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M Riley, David S Khoury, Neil M Ferguson, Azra C Ghani
medRxiv 2022.01.17.22269222; doi: https://doi.org/10.1101/2022.01.17.22269222
The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant
Alexandra B Hogan, Sean L Wu, Patrick Doohan, Oliver J Watson, Peter Winskill, Giovanni Charles, Gregory Barnsley, Eleanor M Riley, David S Khoury, Neil M Ferguson, Azra C Ghani
medRxiv 2022.01.17.22269222; doi: https://doi.org/10.1101/2022.01.17.22269222
Subject Area
Subject Areas
- Addiction Medicine (403)
- Allergy and Immunology (712)
- Anesthesia (207)
- Cardiovascular Medicine (2971)
- Dermatology (253)
- Emergency Medicine (446)
- Epidemiology (12819)
- Forensic Medicine (12)
- Gastroenterology (830)
- Genetic and Genomic Medicine (4623)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2943)
- Health Policy (1073)
- Hematology (393)
- HIV/AIDS (934)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4412)
- Nursing (238)
- Nutrition (653)
- Oncology (2296)
- Ophthalmology (652)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (282)
- Palliative Medicine (84)
- Pathology (503)
- Pediatrics (1200)
- Primary Care Research (503)
- Public and Global Health (7008)
- Radiology and Imaging (1545)
- Respiratory Medicine (921)
- Rheumatology (445)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (185)